Published in Gene Therapy Weekly, June 5th, 2003
Bax triggers pathologic cell death in a number of diseases, including Parkinson, stroke, heart attack, and degeneration of ovaries during menopause.
These results, published online May 4, 2003, in Nature, suggest a novel target for therapeutic design based on inhibiting the cell destructive activity of Bax.
Bax protein is known to promote apoptosis latent in all cells. It does so by attacking the cell's powerhouse, the mitochondria,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-06-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.